Diabetes technology

Dysglycemic Events after Initiation of Intermittently Scanned Continuous Glucose Monitoring in Patients with Insulin-Treated Type 2 Diabetes

Diabetes Technol TherPublished Observational comparative effectiveness study

Authors' conclusion

Initiating isCGM was associated with improved glycemia (reduced A1c, more patients with A1c <8% and <9%), but not the incidence of acute dysglycemic (hypoglycemic or hyperglycemic) events.

Study context

Population
Patients with insulin-treated T2D
Exposure
isCGM vs SMBG
Outcome
Glycemia and acute dysglycemic events
Follow-up
Pre-post
Methodological detailsdifference-in-differences framework, overlap weighting based on propensity scores
  • Difference-in-differences framework
  • Overlap weighting based on propensity scores

Main finding

As reported in the abstract

pre-post
  • Initiating isCGM associated with improved glycemia (reduced HbA1c, more patients with HbA1c <8% and <9%)
  • Initiating isCGM not associated with incidence of acute dysglycemic (hypoglycemic or hyperglycemic) events

Observational data: associations, not effects.

Original publication

Dysglycemic Events after Initiation of Intermittently Scanned Continuous Glucose Monitoring in Patients with Insulin-Treated Type 2 Diabetes. Diabetes Technol Ther. Published 16 April 2025. doi:10.1089/dia.2025.0021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.